{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T09:13:56Z","timestamp":1725700436415},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1985,10]]},"DOI":"10.1007\/bf00313869","type":"journal-article","created":{"date-parts":[[2004,10,13]],"date-time":"2004-10-13T08:08:00Z","timestamp":1097654880000},"page":"301-303","source":"Crossref","is-referenced-by-count":10,"title":["Acute hepatitis in a patient treated with carbamazepine"],"prefix":"10.1007","volume":"232","author":[{"given":"D.","family":"Galeone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lamontanara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Torelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1528-1157.1975.tb04733.x","volume":"16","author":"HE Booker","year":"1975","unstructured":"Booker HE (1975) Idiosynchratic reactions due to the antiepileptic drugs. Epileps\u00eda 16:171?181","journal-title":"Epileps\u00eda"},{"key":"CR2","unstructured":"Bossi L (1979) Effetti indesiderati di farmaci antiepilettici: review della letteratura. Lega Italiana contro l'Epilessia, bollettino no. 25?26, pp 5?19"},{"key":"CR3","first-page":"158","volume-title":"Clinical pharmacology of antiepileptic drugs","author":"JW Faigle","year":"1975","unstructured":"Faigle JW, Feldman EE (1975) Pharmacokinetic data of carbamazepine and its major metabolites in man. In: Schneider H (ed) Clinical pharmacology of antiepileptic drugs. Springer, Berlin Heidelberg New York, p 158"},{"key":"CR4","first-page":"74","volume":"14","author":"J Fuhr","year":"1964","unstructured":"Fuhr J (1964) Investigation on the compatibility and elimination of a new antiepileptic drug. Arzneimittelforsch 14:74?75","journal-title":"Arzneimittelforsch"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ijc.2910160511","volume":"16","author":"HR Glatt","year":"1975","unstructured":"Glatt HR, Oesch F, Frigerio A, Garattini S (1975) Epoxides metabolically produced from clinically used drugs. Int J Cancer 16:787","journal-title":"Int J Cancer"},{"key":"CR6","first-page":"112","volume":"10","author":"S Goenechea","year":"1972","unstructured":"Goenechea S, Hecke-Seibicke E (1972) Contribution to the metabolism of carbamazepine. Z Klin Chem 10:112?113","journal-title":"Z Klin Chem"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archneur.1968.00480020015001","volume":"19","author":"JM Killian","year":"1968","unstructured":"Killian JM, Fromm GH (1968) Carbamazepine in the treatment of neuralgia. Arch Neurol 19:139","journal-title":"Arch Neurol"},{"key":"CR8","unstructured":"Klatskin G (1969) Toxic and drug-induced hepatitis. In: Schoff L (ed) Disease of the liver, 3rd edn. Philadelphia, pp 498?601"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.0954-6820.1980.tb01205.x","volume":"208","author":"GH Levander","year":"1980","unstructured":"Levander GH (1980) Granulomatous hepatitis in a patient receiving carbamazepine. Acta Med Scand 208:333?335","journal-title":"Acta Med Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7326\/0003-4819-95-1-64","volume":"95","author":"M Levy","year":"1981","unstructured":"Levy M, Goodman MW, Van Dyne B, Sumner HW (1981) Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med 95:64?65","journal-title":"Ann Intern Med"},{"key":"CR11","first-page":"144","volume":"19","author":"G Morello","year":"1967","unstructured":"Morello G, Pluchino F (1967) Carbamazepine in the treatment of essential trigeminal neuralgia. Sist Nerv 19:144?152","journal-title":"Sist Nerv"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03602537508993750","volume":"4","author":"PL Morselli","year":"1975","unstructured":"Morselli PL, Frigerio A (1975) Metabolism and pharmacokinetics of carbamazepine. Drug Metab Rev 4:97","journal-title":"Drug Metab Rev"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1528-1157.1975.tb04733.x","volume":"16","author":"GL Plaa","year":"1975","unstructured":"Plaa GL (1975) Acute toxicity of antiepileptic drugs. Epilepsia 16:171?181","journal-title":"Epilepsia"},{"key":"CR14","volume-title":"Progress in liver disease, vol 3","author":"H Popper","year":"1970","unstructured":"Popper H, Schaffner F (1970) Progress in liver disease, vol 3. Grune and Stratton, New York"},{"key":"CR15","first-page":"183","volume":"67","author":"S Posen","year":"1977","unstructured":"Posen S (1977) Alkaline phosphatase. Ann Intern Med 67:183","journal-title":"Ann Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.4.5572.155","volume":"4","author":"JD Ramsay","year":"1967","unstructured":"Ramsay JD (1967) Carbamazepine-induced jaundice. Br Med J 4:155","journal-title":"Br Med J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/cpt1976193276","volume":"19","author":"A Rane","year":"1976","unstructured":"Rane A, Hojer B, Wilson JT (1976) Kinetics of carbamazepine and its 10?11 epoxide metabolite in children. Clin Pharmacol Ther 19:276","journal-title":"Clin Pharmacol Ther"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(70)80129-2","volume":"49","author":"H Remmer","year":"1970","unstructured":"Remmer H (1970) The role of the liver in drug metabolism. Am J Med 49:617","journal-title":"Am J Med"},{"key":"CR19","first-page":"15","volume-title":"Clinical neuropharmacology, vol 3","author":"AS Troupin","year":"1978","unstructured":"Troupin AS (1978) Carbamazepine in epilepsy. In: Klawans HL (ed) Clinical neuropharmacology, vol 3. Raven Press, New York, pp 15?38"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3476(77)80529-5","volume":"91","author":"P Zucker","year":"1977","unstructured":"Zucker P, Daum F, Cohen MI (1977) Fatal carbamazepine hepatitis. J Pediatr 91:667?668","journal-title":"J Pediatr"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00313869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00313869\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00313869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T15:08:12Z","timestamp":1554304092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00313869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["BF00313869"],"URL":"https:\/\/doi.org\/10.1007\/bf00313869","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}